N/A
Manufactured by BM Private Limited
24 FDA adverse event reports analyzed
Last updated: 2026-04-15
BERBERIS VULGARIS ROOT BARK is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by BM Private Limited. The most commonly reported adverse reactions for BERBERIS VULGARIS ROOT BARK include ABDOMINAL PAIN, BACK PAIN, BLOOD TESTOSTERONE INCREASED, DIPLOPIA, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for BERBERIS VULGARIS ROOT BARK.
Out of 3 classified reports for BERBERIS VULGARIS ROOT BARK:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 24 FDA FAERS reports that mention BERBERIS VULGARIS ROOT BARK. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ABDOMINAL PAIN, BACK PAIN, BLOOD TESTOSTERONE INCREASED, DIPLOPIA, DRUG INEFFECTIVE, DRUG INTERACTION. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list BM Private Limited in connection with BERBERIS VULGARIS ROOT BARK. Always verify the specific product and NDC with your pharmacist.